Aydem Yenilenebilir Enerji A.S. (IST:AYDEM)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions TRY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,804	16,466	12,231	18,503	4,195	-
Market Cap Growth	34.63%	34.63%	-33.90%	341.09%	-	-
Enterprise Value	34,572	36,562	29,192	30,245	9,650	-
PE Ratio	-	-	-	3.72	-	-
PS Ratio	1.94	2.50	1.33	2.45	3.38	-
PB Ratio	0.47	0.60	0.30	0.63	0.43	-
P/FCF Ratio	4.35	5.60	3.78	4.07	3.80	-
P/OCF Ratio	3.52	4.53	1.92	2.73	3.22	-
EV/Sales Ratio	5.25	5.55	3.18	4.00	7.78	-
EV/EBITDA Ratio	8.62	9.30	4.91	4.96	10.88	-
EV/EBIT Ratio	34.43	36.41	9.81	7.55	21.99	-
EV/FCF Ratio	11.75	12.43	9.02	6.66	8.74	-
Debt / Equity Ratio	0.89	0.89	0.70	0.74	1.03	0.84
Debt / EBITDA Ratio	6.08	6.08	4.81	3.54	11.29	4.98
Debt / FCF Ratio	8.28	8.28	8.99	4.80	9.14	4.96
Quick Ratio	0.87	0.87	1.94	1.67	1.93	0.33
Current Ratio	1.00	1.00	2.27	1.91	1.99	0.36
Asset Turnover	0.10	0.10	0.13	0.18	0.07	0.12
Return on Equity (ROE)	-34.27%	-34.27%	-5.23%	25.42%	-1.53%	-11.00%
Return on Assets (ROA)	0.92%	0.92%	2.66%	6.09%	1.57%	3.52%
Return on Capital (ROIC)	1.03%	1.03%	3.06%	7.06%	1.78%	5.20%
Return on Capital Employed (ROCE)	2.00%	2.00%	3.90%	7.00%	2.00%	5.50%
Earnings Yield	-91.93%	-71.48%	-15.11%	26.88%	-2.87%	-
Earnings Yield	-91.93%	-71.48%	-15.11%	26.88%	-2.87%	-
FCF Yield	22.98%	17.87%	26.46%	24.55%	26.31%	-
Dividend Yield	2.98%	-	3.17%	-	-	-
Buyback Yield / Dilution	0.27%	0.27%	0.01%	0.36%	-0.48%	-
Total Shareholder Return	3.26%	0.27%	3.18%	0.36%	-0.48%	-

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.